Literature DB >> 14644726

Trypan blue staining in vitreoretinal surgery.

Francisco Aguilera Teba1, Andreas Mohr, Claus Eckardt, David Wong, Shunji Kusaka, Brian C Joondeph, Eric J Feron, Peter Stalmans, Koen Van Overdam, Gerrit R J Melles.   

Abstract

PURPOSE: To evaluate the efficacy of trypan blue for staining the internal limiting membrane (ILM) and epiretinal membranes (ERM) in vitreoretinal surgery.
DESIGN: Prospective noncomparative case series. PARTICIPANTS: Fifty eyes of 50 patients with macular pucker (n = 22), macular hole (n = 18), or a combination (n = 2), proliferative vitreoretinopathy (n = 5), or diabetic retinopathy (n = 3).
METHODS: Trypan blue 0.2% was used to stain the ILM or ERM during vitreoretinal surgery. MAIN OUTCOME MEASURES: The intraoperative visibility of the membranes was scored as poor, moderate, good, or excellent.
RESULTS: The application of trypan blue onto the ILM or the ERM resulted in a useful bluish staining, facilitating the identification, delineation, and removal of the membranes in all surgeries. No residual staining or adverse effects related to the dye were observed.
CONCLUSIONS: Trypan blue stains both ILM and ERM and might be an useful tool in vitreoretinal surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644726     DOI: 10.1016/s0161-6420(03)00716-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Which colour suits the vitreoretinal surgeon?

Authors:  Nanny Collaer; Peter Stalmans
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

2.  Soluble lutein in combination with brilliant blue as a new dye for chromovitrectomy.

Authors:  Emmerson Badaro; Bruno Furlani; Juliana Prazeres; Mauricio Maia; Acácio Alves Souza Lima; Diogo Souza-Martins; Cristina Muccioli; Luiz Filipe Adami Lucatto; Rubens Belfort
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01-19       Impact factor: 3.117

3.  Comparative evaluation of anatomical and functional outcomes using brilliant blue G versus triamcinolone assisted ILM peeling in macular hole surgery in Indian population.

Authors:  Atul Kumar; Varun Gogia; Vinit M Shah; Tapas C Nag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-14       Impact factor: 3.117

4.  A comparison of outcomes after indocyanine green and trypan blue assisted internal limiting membrane peeling during macular hole surgery.

Authors:  K L Lee; S Dean; S Guest
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

5.  Heavy trypan blue staining of epiretinal membranes: an alternative to infracyanine green.

Authors:  Sarit Y Lesnik Oberstein; Marco Mura; Stevie H Tan; Marc D de Smet
Journal:  Br J Ophthalmol       Date:  2007-07       Impact factor: 4.638

6.  Investigation of the retinal biocompatibility of acid violet for chromovitrectomy.

Authors:  Emmerson Badaró Cardoso; Milton Moraes-Filho; Eduardo B Rodrigues; Mauricio Maia; Fernando M Penha; Eduardo Amorim Novais; Rodrigo A Souza-Lima; Carsten H Meyer; Michel Eid Farah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-18       Impact factor: 3.117

7.  Comparison of macular function and visual fields after membrane blue or infracyanine green staining in vitreoretinal surgery.

Authors:  Katharina E Schmid-Kubista; Peggy D Lamar; Alexandra Schenk; Ulrike Stolba; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-13       Impact factor: 3.117

Review 8.  [Heavy liquids as intraoperative instrument in retinal surgery].

Authors:  Karl Boden; K Januschowski; P Szurman
Journal:  Ophthalmologe       Date:  2019-10       Impact factor: 1.059

9.  Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells.

Authors:  A K H Kwok; C-K Yeung; T Y Y Lai; K-P Chan; C P Pang
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

10.  Progressive atrophy of retinal pigment epithelium after trypan-blue-assisted ILM peeling for macular hole surgery.

Authors:  Sachin Jain; Kamal Kishore; Yog Raj Sharma
Journal:  Indian J Ophthalmol       Date:  2013-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.